Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

How Should Peritoneal (Abdominal Lining) Metastases in Gastrointestinal Cancers Be Assessed?

How Should Peritoneal (Abdominal Lining) Metastases in Gastrointestinal Cancers Be Assessed?

Annals of Surgical Oncologypublished research showing that experienced cancer surgeons, during laparoscopy (keyhole surgery) for gastrointestinal cancers, distinguish benign peritoneal (abdominal lining) lesions from metastases with an unacceptably high error rate if they use the appearance of the lesion alone.

The peritoneum (abdominal lining) is one of the organs to which gastrointestinal cancers most often metastasize, and identifying peritoneal metastases is critical to intraoperative staging. However, benign peritoneal lesions exist even in people without cancer, making visual assessment during surgery difficult. In many cases, individually biopsying every visible lesion and awaiting the result is considered unsuitable, and decisions on which lesions to biopsy are based on their gross physical features.

This study, between 2014 and 2017 at Lahey Hospital in Massachusetts, United States, included 35 patients undergoing video-recorded laparoscopic gastrointestinal cancer surgery performed by a single surgeon (excluding esophageal, liver and colorectal cancers).

Every peritoneal lesion was biopsied during surgery. A group of 10 experienced gastrointestinal oncology surgeons, not informed that the lesions had been biopsied, classified them as benign or metastatic based on appearance.

In addition, 3 experienced investigators unaware of biopsy results analyzed lesion size, color and gradient (changes in brightness at each lesion’s edges) using digital image processing software ImageJ . The lesions were also evaluated using a deep artificial neural network machine learning model.

Study results

  • Pathology results found that % 68 of the lesions included were benign and % 32 metastatic.
  • The experienced gastrointestinal oncology surgeons classified % 36 of peritoneal metastases as benign (the false-negative rate). In other words, when estimating solely from a lesion’s appearance, they called %36 of genuinely cancerous lesions benign.
  • ImageJ distinguished benign from malignant lesions with %66 accuracy and the machine learning model with %47 accuracy. Based on these findings, the researchers emphasized that all visible peritoneal lesions in gastrointestinal cancers should be assessed by biopsy during laparoscopy.

Sources

Schnelldorfer T, Ware MP, Liu LP, et al.
Can we accurately identify peritoneal metastases based on their appearance? An assessment of the current practice of intraoperative gastrointestinal cancer staging.
Ann Surg Oncol, 25 March 2019.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

How Should Peritoneal (Abdominal Lining) Metastases in Gastrointestinal Cancers Be Assessed?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy